Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunoliposomes for the targeted delivery of antitumor drugs.
Mastrobattista E, Koning GA, Storm G. Mastrobattista E, et al. Among authors: koning ga. Adv Drug Deliv Rev. 1999 Nov 10;40(1-2):103-127. doi: 10.1016/s0169-409x(99)00043-5. Adv Drug Deliv Rev. 1999. PMID: 10837783
Strategies for cytosolic delivery of liposomal macromolecules.
Fretz MM, Mastrobattista E, Koning GA, Jiskoot W, Storm G. Fretz MM, et al. Among authors: koning ga. Int J Pharm. 2005 Jul 25;298(2):305-9. doi: 10.1016/j.ijpharm.2005.02.040. Int J Pharm. 2005. PMID: 15941633 Review.
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.
Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G. Schiffelers RM, et al. Among authors: koning ga. J Control Release. 2003 Aug 28;91(1-2):115-22. doi: 10.1016/s0168-3659(03)00240-2. J Control Release. 2003. PMID: 12932643
Ligand-targeted liposomes directed against pathological vasculature.
Schiffelers RM, Molema G, ten Hagen TL, Janssen AP, Schraa AJ, Kok RJ, Koning GA, Storm G. Schiffelers RM, et al. Among authors: koning ga. J Liposome Res. 2002 Feb-May;12(1-2):129-35. doi: 10.1081/lpr-120004785. J Liposome Res. 2002. PMID: 12604046
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page